Asia Pacific hemodynamic monitoring systems market will grow by 8.0% annually with a total addressable market cap of $4,242.7 million over 2022-2031, driven by the rising prevalence of cardiovascular diseases & diabetes, increasing geriatric population, the introduction of more innovative and non-invasive devices, extensive research and development (R&D) activities, and the increasing healthcare concerns and expenditure amid COVID-19 pandemic.
Highlighted with 28 tables and 41 figures, this 105-page report Asia Pacific Hemodynamic Monitoring Systems Market 2021-2031 by Component (Catheters, Sensors, Monitoring Devices, Probes, Others), Modality (Invasive, Minimally Invasive, Non-Invasive), Setting (Hospitals, Clinics, Ambulatory Care Units, Homecare, Others), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific hemodynamic monitoring systems market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific hemodynamic monitoring systems market in every aspect of the classification from perspectives of Component, Modality, Setting, and Country.
Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Catheters
Sensors
Monitoring Devices
Probes
Other Components
Based on Modality, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Invasive Monitoring
Minimally Invasive Monitoring
Non-Invasive Monitoring
By Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Hospitals
Clinics
Ambulatory Care Units
Homecare
Other Settings
Geographically, the following national/local markets are fully investigated:
Japan
China
South Korea
Australia
India
Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Modality, and Setting over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Baxter International Inc.
Caretaker, LLC
Cheetah Medical Inc.
CN Systems Medizintechnik GmbH
Deltex Medical Group PLC
Dragerwerk AG & Co. KGaA
Edwards Lifesciences Corporation
Flosonics Medical
GE Healthcare
Getinge Group
Heart Kinetics
ICU Medical Inc.
Koninklijke Philips N.V.
Lidco Group PLC
Masimo Corporation
NI Medical Ltd.
Osypka Medical GmbH
Retia Medical
Schwarzer Cardiotek
Sramek BioDynamics Inc.
Uscom Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
